Show
Sort by
-
- Journal Article
- A1
- open access
Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry : a pilot study
-
- Miscellaneous
- open access
Response to Tsikas et al. comments on Boelaert et al. Determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease: UPLC-MS/MS versus ELISA. Toxins 2016, 8, 149
-
- Journal Article
- A1
- open access
Determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease: UPLC-MS/MS versus ELISA
-
New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy
-
- PhD Thesis
- open access
Development of metabolic analytical platforms for the characterization of uremic retention compounds
(2014) -
- Conference Paper
- C3
- open access
Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry: a pilot study
-
State-of-the-art non-targeted metabolomics in the study of chronic kidney disease
-
- Conference Paper
- C3
- open access
Determination of asymmetric and symmetric dimethylarginine in serum from patients with chronic kidney disease : UPLC-MS/MS versus ELISA
-
- Conference Paper
- C3
- open access
Metabolic profiling by hydrophilic interaction ultra-performance liquid chromatography time-of-flight mass spectrometry in the study of chronic kidney disease
-
- Conference Paper
- C3
- open access
LC- and GC-MS-based non-targeted metabolomics in the study of chronic kidney disease